Tongze Conway's IPO was approved by the listing committee of the Shenzhen Stock Exchange. Its main customers include China Telecom Corporation and other major telecommunications companies worldwide.
On June 30th, Guangzhou Tongze Kangwei Technology Co., Ltd. (referred to as Tongze Kangwei) IPO was approved by the listing committee of the Shenzhen Stock Exchange. The sponsor for this IPO is CITIC Securities.
On June 30th, Guangzhou Tongzhe Kangwei Technology Co., Ltd. (referred to as Tongzhe Kangwei) went public through the Shenzhen Stock Exchange Listing Committee. The sponsor for this IPO is China Securities Co., Ltd.
According to the prospectus, Tongzhe Kangwei is mainly engaged in the design, research and development, production, and sales of self-owned series of broadband access terminal equipment. The company primarily provides products and services directly to global telecom operators and actively expands its application to vertical industry customers. With a full range of multi-platform broadband access products, Tongzhe Kangwei aims to meet the global broadband connectivity needs in the era of artificial intelligence, making it more inclusive, convenient, integrated, and smart. The company is a key technology enterprise focusing on the ICT sector introduced by the Nansha District government in Guangzhou, with a core team possessing over twenty years of experience in the ICT sector. Since its establishment, the company has been committed to becoming a global provider of broadband access terminals and intelligent solutions, serving global telecom operators and industry customers to promote innovative development in global mobile communication technology applications.
The company adheres to the business philosophy of research and development-driven development and focuses on the industrialization strategy of technology going global. After years of development, Tongzhe Kangwei has built a product technology platform based on mainstream communication chips such as Unisoc, ZTE Micro, MediaTek, and Qualcomm, with products widely used in 4G/5G wireless broadband connections in home, government, business, and industrial settings. The core customers include major global operators such as EITC, Ooredoo, MTN, Airtel, Vodafone, Axiata, Orange, China Mobile Limited, China United Network Communications, and China Telecom Corporation, with products sold to over 80 countries and regions in Asia-Pacific, Middle East, Africa, America, and Europe.
The company has established a broadband access terminal application technology platform, achieved technology reuse and core technology breakthroughs through technological platformization and modularization, and actively responded to customer demand during the business development by continuously expanding its product series and new application areas. Through the synergy of technology and customer effects, Tongzhe Kangwei has created a "prominent core, complete series, continuously enriched" product matrix.
The company is a national-level key innovative and specialized enterprise, a national-level high-tech enterprise, and a champion enterprise in Guangdong Province's manufacturing industry. It has the Guangdong 5G CPE/Wireless Router Engineering Technology Research Center and a doctoral workstation in Guangdong Province, with numerous core technologies in communication module and whole machine design, multi-level software development, network optimization and data processing, network platform management, network security, and redundant processing.
As of December 31, 2024, the company has obtained 83 invention patents, 78 software copyrights, with research and development personnel accounting for 57.06%. It has been recognized as an "Future Unicorn" innovation enterprise and "High-Precision" enterprise in Guangzhou, the most promising leading enterprise in Guangzhou, a key platform enterprise in Guangzhou's "Four Transformations" empowerment, an innovative SME in Guangdong Province, and has been listed in the top 100 high-growth innovative companies in Guangzhou, and top 30 high-tech enterprises in Nansha District.
In terms of finance, in the years 2022, 2023, and 2024, the company achieved operating income of approximately 962 million, 1.025 billion, and 1.152 billion RMB, respectively. During the same period, the net profit was 95 million, 107 million, and 80 million RMB, respectively.
Related Articles
.png)
CSPC PHARMA (01093) has received a $25 million research and development milestone payment from AstraZeneca under a strategic collaboration and licensing agreement.

US Stock Market Move | Concept stocks related to optical communication generally fell, with Applied Optoelectronics (AAOI.US) dropping more than 6%.

GUMING (01364) spent HK$5.758 million to repurchase 288,000 shares on July 10th.
CSPC PHARMA (01093) has received a $25 million research and development milestone payment from AstraZeneca under a strategic collaboration and licensing agreement.
.png)
US Stock Market Move | Concept stocks related to optical communication generally fell, with Applied Optoelectronics (AAOI.US) dropping more than 6%.

GUMING (01364) spent HK$5.758 million to repurchase 288,000 shares on July 10th.

RECOMMEND





